NAPKON Pediatrics Module
1.0.0 - trial-use
NAPKON Pediatrics Module - Local Development build (v1.0.0). See the Directory of published versions
{
"resourceType" : "MedicationStatement",
"id" : "ImmunosuppresivePermanentMedication",
"meta" : {
"profile" : [
"https://www.napkon.de/fhir/StructureDefinition/immunosuppresive-permanent-medication"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>status</b>: completed</p><p><b>medication</b>: <span title=\"Codes: {https://www.napkon.de/fhir/CodeSystem/napkon-pediatrics-module P7}, {http://fhir.de/CodeSystem/bfarm/atc L01XC19}\">Anti-CD3/CD19 antibody</span></p><p><b>subject</b>: <a href=\"Patient-ExamplePatient.html\">Generated Summary: Medical record number: napkon-example-patient; maxi musterperson (OFFICIAL); gender: unknown; birthDate: 1990-08-08</a></p><p><b>effective</b>: Sep 14, 2021, 11:06:00 AM</p></div>"
},
"status" : "completed",
"medicationCodeableConcept" : {
"coding" : [
{
"system" : "https://www.napkon.de/fhir/CodeSystem/napkon-pediatrics-module",
"code" : "P7",
"display" : "Anti-CD3/CD19 antibody"
},
{
"system" : "http://fhir.de/CodeSystem/bfarm/atc",
"code" : "L01XC19",
"display" : "Blinatumomab"
}
]
},
"subject" : {
"reference" : "Patient/ExamplePatient"
},
"effectiveDateTime" : "2021-09-14T13:06:00+02:00"
}